Ignite Creation Date:
2024-05-06 @ 12:13 PM
Last Modification Date:
2024-10-26 @ 12:55 PM
Study NCT ID:
NCT03703050
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2018-10-09
Brief Title:
Nivolumab for Pediatric and Adult RelapsingRefractory ALK for Evaluation of Response in Patients With Progressive Disease Cohort 1 or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse Cohort 2
Sponsor:
Organization:
Gustave Roussy Cancer Campus Grand Paris